Kaleido Biosciences (KLDO) Competitors $0.0002 0.00 (0.00%) As of 03:34 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock KLDO vs. ELYS, PRST, GROM, KBNT, ALFIW, APCXW, ARBEW, AOGOW, AOGOU, and AUROWShould you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include Elys BMG Group (ELYS), Presto Automation (PRST), Grom Social Enterprises (GROM), Kubient (KBNT), Alfi (ALFIW), AppTech Payments (APCXW), Arbe Robotics (ARBEW), Arogo Capital Acquisition (AOGOW), Arogo Capital Acquisition (AOGOU), and Aurora Innovation (AUROW). These companies are all part of the "computer software" industry. Kaleido Biosciences vs. Elys BMG Group Presto Automation Grom Social Enterprises Kubient Alfi AppTech Payments Arbe Robotics Arogo Capital Acquisition Arogo Capital Acquisition Aurora Innovation Elys BMG Group (NASDAQ:ELYS) and Kaleido Biosciences (NASDAQ:KLDO) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, community ranking, analyst recommendations and earnings. Which has more volatility and risk, ELYS or KLDO? Elys BMG Group has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Comparatively, Kaleido Biosciences has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Which has higher valuation and earnings, ELYS or KLDO? Elys BMG Group has higher revenue and earnings than Kaleido Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElys BMG Group$43.86M0.00-$18.26MN/AN/AKaleido Biosciences$1.10M0.01-$95.48M-$2.240.00 Do institutionals and insiders believe in ELYS or KLDO? 81.6% of Kaleido Biosciences shares are owned by institutional investors. 18.5% of Elys BMG Group shares are owned by company insiders. Comparatively, 9.0% of Kaleido Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer ELYS or KLDO? In the previous week, Elys BMG Group had 2 more articles in the media than Kaleido Biosciences. MarketBeat recorded 2 mentions for Elys BMG Group and 0 mentions for Kaleido Biosciences. Kaleido Biosciences' average media sentiment score of 0.76 beat Elys BMG Group's score of 0.32 indicating that Kaleido Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Elys BMG Group Neutral Kaleido Biosciences Positive Does the MarketBeat Community favor ELYS or KLDO? Kaleido Biosciences received 36 more outperform votes than Elys BMG Group when rated by MarketBeat users. However, 75.00% of users gave Elys BMG Group an outperform vote while only 57.45% of users gave Kaleido Biosciences an outperform vote. CompanyUnderperformOutperformElys BMG GroupOutperform Votes1875.00% Underperform Votes625.00% Kaleido BiosciencesOutperform Votes5457.45% Underperform Votes4042.55% Is ELYS or KLDO more profitable? Company Net Margins Return on Equity Return on Assets Elys BMG GroupN/A N/A N/A Kaleido Biosciences N/A N/A N/A SummaryElys BMG Group beats Kaleido Biosciences on 6 of the 10 factors compared between the two stocks. Get Kaleido Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLDO vs. The Competition Export to ExcelMetricKaleido BiosciencesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$9,000.00$129.09M$5.42B$8.48BDividend YieldN/A3.74%5.22%4.11%P/E Ratio0.003.4626.8320.05Price / Sales0.014,140.76393.86117.02Price / CashN/A13.1938.2534.62Price / BookN/A33.226.874.61Net Income-$95.48M-$91.56M$3.22B$248.19M7 Day PerformanceN/A3.44%5.65%2.88%1 Month PerformanceN/A7.98%13.54%15.40%1 Year PerformanceN/A102.27%18.16%7.68% Kaleido Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLDOKaleido BiosciencesN/A$0.00flatN/AN/A$9,000.00$1.10M0.0080News CoverageELYSElys BMG GroupN/A$0.00flatN/A-99.7%$16,000.00$43.86M0.0090PRSTPresto AutomationN/A$0.00+∞N/AN/A$10,000.00$19.05M0.004Gap UpGROMGrom Social EnterprisesN/A$0.00flatN/A-99.8%$8,000.00$3.72M0.00450KBNTKubientN/A$0.00flatN/AN/A$1,000.00$1.17M0.0040ALFIWAlfiN/AN/AN/AN/A$0.00$200,684.000.0040APCXWAppTech PaymentsN/A$0.11+8.9%N/A-72.5%$0.00$276,000.000.0020Positive NewsARBEWArbe RoboticsN/A$0.25+5.8%N/A+83.5%$0.00$768,000.000.00120Positive NewsGap UpAOGOWArogo Capital AcquisitionN/A$0.02flatN/AN/A$0.00N/A0.00N/AAOGOUArogo Capital AcquisitionN/A$8.50flatN/AN/A$0.00N/A0.00N/AAUROWAurora InnovationN/A$1.77+7.2%N/A+369.9%$0.00$2M0.001,700Gap Up Related Companies and Tools Related Companies Elys BMG Group Competitors Presto Automation Competitors Grom Social Enterprises Competitors Kubient Competitors Alfi Competitors AppTech Payments Competitors Arbe Robotics Competitors Arogo Capital Acquisition Competitors Arogo Capital Acquisition Competitors Aurora Innovation Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLDO) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaleido Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kaleido Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KLDO Stock Free KLDO Stock Alerts